90 related articles for article (PubMed ID: 8166436)
1. Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice.
Landrito JE; Yoshiga K; Sakurai K; Takada K
Anticancer Res; 1994; 14(1A):113-8. PubMed ID: 8166436
[TBL] [Abstract][Full Text] [Related]
2. Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.
Landrito JE; Yoshiga K; Sakurai K; Takada K
Cancer Chemother Pharmacol; 1994; 34(4):323-30. PubMed ID: 8033299
[TBL] [Abstract][Full Text] [Related]
3. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
Nagase M; Nomura T; Nakajima T
Cancer Treat Rep; 1987 Sep; 71(9):825-9. PubMed ID: 3621215
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
5. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
8. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
9. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
[TBL] [Abstract][Full Text] [Related]
10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
11. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
12. Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.
Hecquet B; Depadt G; Fournier C; Meynadier J
Anticancer Res; 1986; 6(1):65-9. PubMed ID: 3954334
[TBL] [Abstract][Full Text] [Related]
13. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.
Fu KK; DeGregorio MW; Phillips JW
NCI Monogr; 1988; (6):123-7. PubMed ID: 3281027
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma.
Chung PS; Rhee CK; Kim KH; Paek W; Chung J; Paiva MB; Eshraghi AA; Castro DJ; Saxton RE
Laryngoscope; 2000 Aug; 110(8):1312-6. PubMed ID: 10942132
[TBL] [Abstract][Full Text] [Related]
15. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
16. [Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report].
Nemoto H; Takeuchi S; Yoshizawa Y; Uemichi O; Sasaya S; Yamaguchi M; Makuuchi M; Midorikawa T; Sanada Y; Kumada K; Takizawa K
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1149-53. PubMed ID: 11525035
[TBL] [Abstract][Full Text] [Related]
17. Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system.
Begg AC; Bartelink H; Stewart FA; Brown DM; Luck EE
NCI Monogr; 1988; (6):133-6. PubMed ID: 3352754
[TBL] [Abstract][Full Text] [Related]
18. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
[TBL] [Abstract][Full Text] [Related]
19. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
Kojima H; Iida M; Yaguchi Y; Suzuki R; Hayashi N; Moriyama H; Manome Y
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
